BRUKER CORPORATION Proceeds from Lines of Credit
BRUKER CORPORATION (BRKR) reported Proceeds from Lines of Credit of $195.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-08-05
- BRUKER CORPORATION proceeds from lines of credit for the quarter ending 2026-06-30 was $195.00M, a 15.86% increase year-over-year.
- BRUKER CORPORATION proceeds from lines of credit for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- BRUKER CORPORATION proceeds from lines of credit for the quarter ending 2025-12-31 was -$15.00M, a 108.48% decline year-over-year.
- BRUKER CORPORATION proceeds from lines of credit for the quarter ending 2025-09-30 was $457.30M, a 457200.00% increase year-over-year.
- BRUKER CORPORATION proceeds from lines of credit for fiscal 2025 was $750.50M, a 39.97% decline from fiscal 2024.
- BRUKER CORPORATION proceeds from lines of credit for fiscal 2024 was $1.25B.
- BRUKER CORPORATION proceeds from lines of credit for fiscal 2023 was $0.00.
- BRUKER CORPORATION proceeds from lines of credit for fiscal 2022 was $0.00.
USD
| Period end | Proceeds from Lines of Credit | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $195.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $195.00M 10-Q · filed 2026-08-05 | $180.00M derived: sum of 3 quarters · filed 2026-08-05 | $637.30M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | -$15.00M derived: sum of 2 quarters · filed 2026-05-07 | $442.30M derived: sum of 3 quarters · filed 2026-05-07 | $610.60M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | -$15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $442.30M derived: sum of 2 quarters · filed 2026-02-27 | $610.60M derived: sum of 3 quarters · filed 2026-08-05 | $750.50M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $457.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $625.60M derived: sum of 2 quarters · filed 2026-08-05 | $765.50M 10-Q · filed 2025-11-05 | $942.40M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $168.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $308.20M 10-Q · filed 2026-08-05 | $485.10M derived: sum of 3 quarters · filed 2026-08-05 | $485.20M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $139.90M 10-Q · filed 2026-05-07 | $316.80M derived: sum of 2 quarters · filed 2026-05-07 | $316.90M derived: sum of 3 quarters · filed 2026-05-07 | $1.12B derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $176.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $177.00M derived: sum of 2 quarters · filed 2026-02-27 | $981.40M derived: sum of 3 quarters · filed 2026-02-27 | $1.25B 10-K · filed 2026-02-27 | |
| 2024-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $804.50M derived: sum of 2 quarters · filed 2025-11-05 | $1.07B 10-Q · filed 2025-11-05 | $1.07B derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $804.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.07B 10-Q · filed 2025-08-06 | $1.07B derived: sum of 3 quarters · filed 2026-02-27 | $1.07B derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $268.90M 10-Q · filed 2025-05-07 | $268.90M derived: sum of 2 quarters · filed 2026-02-27 | $268.90M derived: sum of 3 quarters · filed 2026-02-27 | $268.90M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-01-15 | $269.00M 10-Q · filed 2024-11-07 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-10 | ||||
| 2022-12-31 | $0.00 10-K · filed 2025-03-03 | ||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-01 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $100.00M derived: sum of 3 quarters · filed 2023-03-01 | $297.50M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $100.00M derived: sum of 2 quarters · filed 2021-11-05 | $297.50M 10-Q · filed 2021-11-05 | $297.50M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $100.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $297.50M 10-Q · filed 2021-08-05 | $297.50M derived: sum of 3 quarters · filed 2022-02-28 | $347.50M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | $197.50M 10-Q · filed 2021-05-10 | $197.50M derived: sum of 2 quarters · filed 2022-02-28 | $247.50M derived: sum of 3 quarters · filed 2022-02-28 | $407.50M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $50.00M derived: sum of 2 quarters · filed 2022-02-28 | $210.00M derived: sum of 3 quarters · filed 2022-02-28 | $250.60M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $210.00M derived: sum of 2 quarters · filed 2020-11-06 | $250.60M 10-Q · filed 2020-11-06 | $352.50M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $160.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $200.60M 10-Q · filed 2020-08-07 | $302.50M derived: sum of 3 quarters · filed 2021-03-01 | $322.50M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $40.60M 10-Q · filed 2020-05-11 | $142.50M derived: sum of 2 quarters · filed 2021-03-01 | $162.50M derived: sum of 3 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $101.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $121.90M derived: sum of 2 quarters · filed 2021-03-01 | $129.40M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $27.50M 10-Q · filed 2019-11-04 | |||
| 2018-06-30 | $7.50M 10-Q · filed 2019-08-09 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $75.00M derived: sum of 2 quarters · filed 2020-03-27 | $121.00M derived: sum of 3 quarters · filed 2020-03-27 | $154.00M 10-K · filed 2020-03-27 | |
| 2017-09-30 | $75.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $121.00M derived: sum of 2 quarters · filed 2018-11-09 | $154.00M 10-Q · filed 2018-11-09 | $201.00M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | $46.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $79.00M 10-Q · filed 2018-08-09 | $126.00M derived: sum of 3 quarters · filed 2019-03-01 | $148.00M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | $33.00M 10-Q · filed 2018-05-10 | $80.00M derived: sum of 2 quarters · filed 2019-03-01 | $102.00M derived: sum of 3 quarters · filed 2019-03-01 | $143.00M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | $47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $69.00M derived: sum of 2 quarters · filed 2019-03-01 | $110.00M derived: sum of 3 quarters · filed 2019-03-01 | $146.00M 10-K · filed 2019-03-01 | |
| 2016-09-30 | $22.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $63.00M derived: sum of 2 quarters · filed 2017-11-09 | $99.00M 10-Q · filed 2017-11-09 | $124.00M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | $41.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $77.00M 10-Q · filed 2017-08-09 | $102.00M derived: sum of 3 quarters · filed 2018-03-16 | $109.00M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | $36.00M 10-Q · filed 2017-05-10 | $61.00M derived: sum of 2 quarters · filed 2018-03-16 | $68.00M derived: sum of 3 quarters · filed 2018-03-16 | ||
| 2015-12-31 | $25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $32.00M derived: sum of 2 quarters · filed 2018-03-16 | $42.00M 10-K · filed 2018-03-16 | ||
| 2015-09-30 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $17.00M 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | $10.00M 10-Q · filed 2016-08-05 |
CHF
| Period end | Proceeds from Lines of Credit |
|---|---|
| 2024-01-15 | 230.00M CHF 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |